Cerbios Pharma SA

Cerbios-Pharma SA (hereinafter referred to as“Cerbios”) is a swiss privately held company located in Barbengo/Lugano in Southern Switzerland specialized in the development and manufacturing of chemical and biological APIs for our partners world-wide but mainly in the USA, Europe, Japan.

 

Our vision is To become a leading company in niche, high value, chemical and biological APIs”  while our mission is “To pursue an aggressive growth plan through the combined offering of self developped APIs and Custom Services”.

 

The exclusive R&D and manufacturing expertise is available to our Pharma partners needing to develop and scale-up NCE or NBE for clinical trials, registration and commercial purpose.

cGMP APIs made by Cerbios cover large molecules and Probiotics (Biological Division) and small molecules (Chemical Division),  sold worldwide mainly to pharma companies within Europe, USA and Japan.

The Biological Division has specialized since 1976 in the research, development and production of Probiotics as active pharmaceutical ingredients, pharmaceutical finished products and feed additives.

On top of that, in the last 15 years, Cerbios has acquired a vast experience on Recombinant Proteins from mammalian cells (CHO) based on a state-of-the-art platform.
Services for third parties under exclusive manufacturing is offered in the area of Recombinant Proteins for the Biological Division.

All services mentioned in the profile are available to our partners only in conjunction with the production of cGMP clinical batches.
Is this your Organization?   Request Access

Locations


Switzerland
Cerbios-Pharma SA
Via Pian Scairolo 6
Lugano / Barbengo, TI  6917
Switzerland, Europe

GMP Experience
Production at Cerbios is performed only under cGMP. GMP certificate from SwissMedic. Last inspection 1/2009 (no observations). FDA inspected (2010) : no 483.

Contacts


Martin Aeschbacher, Ph.D.
Director, M&S Biological Division

Production Lines

Cerbios-Pharma SA   Clinical Batch production unit
Location: Lugano / Barbengo, TI, Switzerland
Main Details
Specialization:  Drug Substance (API)Drug Substance (API)
Platform:  Cell CultureCell Culture
BioReactor Process:  BatchBatch
BioReactor Process:  Fed-BatchFed-Batch
BioReactor Scale:  1L-100L100L Bioreactor
GMP Level:  Phase I/IIPhase I/II
Biosafety Level:  Biosafety Level 1Biosafety Level 1
Single Use:  NoneNone
Additional Services
Analytical Services are AvailableAnalytical Services
Cell Banking is AvailableCell Banking
Cell Line Development is AvailableCell Line Development
Preclinical Manufacturing is AvailablePreclinical Manufacturing
Process Development is AvailableProcess Development
Viral Manufacturing is Not AvailableViral Manufacturing
Availability: Contact CMO

Last Update: 10AUG11

Send Inquiry about this Production Line

Copyright © Kymanox, All Rights Reserved.